PharmaShots | Incisive News in 3 Shots

Subscribe Now

Chronic Inflammatory Demyelinating Polyneuropathy

Pfizer's Panzyga Receives the US FDA's Approval of sBLA for Chronic Inflammatory Demyelinating Polyneuropathy

Pfizer's Panzyga Receives the US FDA's Approval of sBLA for Chronic Inflammatory Demyelinating Polyneuropathy

February 15, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us